Suramin Sodium

苏拉明钠

Report date: 2026/01/05 09:12:24
NME

Base Information

Drug NameSuramin Sodium
Drug Alias Namesuraminum natricum福诺三零九suramine sodique舒拉明钠suramina de sodio +[14] 
ClassificationSmall molecules
Mechanisms of ActionHeparanase inhibitors
TargetsHeparanase
Therapy Area/IndicationsCNS Embryonal TumorAutism Spectrum DisorderAcute Kidney Injury +[11] 
Global Approved IndicationsTrypanosomiasis, AfricanOnchocerciasis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryGermany
Original Approved Date1940/01/01
Country/TerritoryUnited StatesSouth AfricaGermany +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPending
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesBayer AGRediscovery Life Sciences
Inactive CompaniesNational Cancer InstituteUniversity Of California San DiegoEmory University +[6] 
Active IndicationsAcute Kidney InjuryTrypanosomiasis, AfricanOnchocerciasis
Inactive IndicationsCNS Embryonal TumorAutism Spectrum DisorderUrinary Bladder Neoplasms +[8] 

Other Information

ATC CodeP01CX02
Related LinksWikipediaDrugBankKEGG